Searched for
CHEMCON SPECIALTY CHEMICALS
Rupee depreciation brings speciality chemicals space in focus: Galaxy Surfactants, Vinati Organics top picksRupee depreciation brings speciality chemicals space in focus: Galaxy Surfactants, Vinati Organics top picks. The opportunity for exports o...- Book partial profit if Zomato lists at over 30% premiumIn the unofficial market for unlisted shares, known as grey market, Zomato’s unlisted shares are changing hands at around 30 per cent premi...
- Speciality chem firm Clean Science and Tech planning Rs 1,400 cr IPOAxis Capital, JM Financial and Kotak Mahindra Capital company are likely to lead the issue as merchant bankers.
- IPO stocks ride leveraged money but many fall below listing priceExperts caution retail investors as grey market premiums and easy financing drive over-subscription, distort price discovery
- Laxmi Organics raises Rs 180 crore from anchor investors ahead of IPOThe price band has been fixed at Rs 129-130 per share for the IPO, which will open for public subscription during March 15-17.
- 2020 turns out to be the best year for listing day gains on the StreetPublic listings in the latter half of the year gave an average gain of 35 per cent on the first day, besting previous records set in an era...
- Laxmi Organics plans to go public, files draft papers for Rs 800 crore IPOThe IPO is a fresh issuance aggregating to Rs 500 crore and an offer for sale of face value of Rs 2 each by the promoter selling shareholde...
- NSE-BSE bulk deals: BNP Paribas dumps Angel Broking on debutBNP Paribas Arbitrage sold over 5.24 lakh shares of Angel Broking while Alphagrep Securities bought and sold almost the same number of shar...
- NSE-BSE bulk deals: Nomura, Goldman Sachs, Fidelity stock up CAMS on debutVanguard Group bought shares of Can Fin Homes, while Caladium Investment offloaded some of its stake.
- Angel Broking IPO allotment status: Here's how to checkAngel Broking IPO was subscribed 3.94 times. You can now check the allotment status.
- ETIG Analysis: Five reasons why the pharma sector has been the biggest beneficiary of the pandemicThe events of the recent months prompted the government to roll out an incentive scheme to promote the local production of key active ingre...
- IPO investors, beware! Grey market shows strong quality bias from here on“We saw some investors’ reluctance in the Angel Broking IPO. They seem to be getting mindful of the fact that they need to separate the whe...
- Chemcon Specialty Chemicals IPO subscribed 149 times; grey market premium rises to 88%The Vadodara-based company plans to raise Rs 318 crore, out of which it already raised Rs 95.40 crore through allotment of 28.06 lakh share...
- 42 stocks from 2 sectors that doubled money in 2020 still have more steamChart topper Venus Remedies has rallied the most at 546 per cent, followed by Aarti Drugs (up 382 per cent), Mangalam Drugs (375 per cent),...
- Chemcon Speciality IPO subscribed 12.65 times; retail portion filled in 23 timesChemcon Speciality Chemicals IPO will fetch Rs 318 crore at the upper end of the price band. Bidding closes tomorrow.
- Chemcon Speciality Chemicals IPO opens: What do the brokerages saySagar Shah of Ascent Wealth Advisers, an entity that deals in unlisted shares, said Chemcon’s premium in the grey market had risen to Rs 27...
- Chemcon IPO subscribed 78% within 45 mins; retail quota attracts 1.55 times bidsOn Friday, the company raised Rs 95.40 crore through allotment of 28.06 lakh shares to anchor investors at Rs 340 per share.
- Chemcon IPO valuations, Covid update and analyst ratings: Should you subscribe?The issue would comprise of fresh issue of equity shares aggregating up to Rs 165 crore and an offer for sale of up to 45,00,000 equity sha...
- Market Movers: Pharma stocks on a high, Happiest slips; 139 stocks flash buy signalsNagaraj Shetti, Technical Research Analyst, HDFC Securities, said Nifty may trade rangebound with a negative bias in the short term
- You may get happy, happier, happiest on IPO StAll three IPOs are likely to get a good response from the investors following the huge successes of the last three - Rossari Biotech, Happi...
Load More
